Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells
- 2 May 2003
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 304 (2), 378-384
- https://doi.org/10.1016/s0006-291x(03)00590-4
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on ?? cells1Transplantation, 2002
- Thiazolidinediones: metabolic actions in vitroDiabetologia, 2002
- Thiazolidinediones for the prevention of diabetes in the non‐obese diabetic (NOD) mouse: implications for human type 1 diabetesDiabetes/Metabolism Research and Reviews, 2002
- Glitazones: clinical effects and molecular mechanismsAnnals of Medicine, 2002
- Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular EndotheliumBiochemical and Biophysical Research Communications, 2001
- Thiazolidinediones (PPARγ agonists) but not PPAR α agonists increase IRS‐2 gene expression in 3T3‐L1 and human adipocytes1The FASEB Journal, 2000
- Cellular and molecular roles of β cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetesArchives of Pharmacal Research, 1999
- In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage‐derived cytokines in a model of organ‐specific insulitisImmunology, 1999
- Troglitazone Exhibits Immunomodulatory Activity on the Cytokine Production of Activated Human LymphocytesHormone and Metabolic Research, 1999
- Insulin Therapy of Prediabetes Suppresses TH1 Associated Gene Expression in BB Rat PancreasAutoimmunity, 1997